Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Long-term Safety in Adolescent Schizophrenia
NCT01001702Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Apr 2006
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Apr 2006; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01001702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001702.